References
1
Valencia E.
Patra A.
Freyer AJ.
Shamma M.
Fajardo V.
Tetrahedron
Lett.
1984,
25:
3163
2 Lewis WH, Stonard RJ, Porras-Reyes B, Mustoe TA, and Thomas A. inventors; US
Patent 5156847.
3a
Khan MA.
Gemal AL.
J.
Heterocyclic Chem.
1977,
14:
1009
3b
Tabakovic K.
Tabakovic I.
Trkovnik M.
Juric A.
Trinajstic N.
J.
Heterocycl. Chem.
1980,
17:
801
3c
Sagi M.
Wada K.
Konno S.
Yamanaka H.
Heterocycles
1990,
30:
1009
4a
Dean FM.
Robertson A.
Whalley WB.
J. Chem. Soc.
1950,
895
4b
Trivedi KN.
Sethna S.
J. Org. Chem.
1960,
25:
1817
5
Islam AM.
Raphael RA.
J. Chem. Soc.
1955,
3151
6a
Ciblat S.
Calinaud P.
Canet J.-L.
Troin Y.
J.
Chem. Soc., Perkin Trans. 1
2000,
353
6b
Rougnon-Glasson S.
Canet J.-L.
Troin Y.
Tetrahedron Lett.
2000,
41:
9797
7
Greenhill JV.
Mohamed MI.
J. Chem. Soc., Perkin Trans.
1
1979,
1411
8
Heber D.
Berghaus T.
J. Heterocycl. Chem.
1994,
31:
1353
9
General procedure
for the synthesis of pyrido[2,3-
c
]coumarins 5. In a round bottom
flask equipped with a Dean-Stark apparatus, 3-hydroxycoumarins 3 in toluene, CSA (cat.) and amines 4 (1.1 equiv) were added. The solution
was refluxed 5 h. The solution was cooled to r.t and 1.5 equiv of
BF3˙Et2O was added. The solution
was refluxed 18 h and the solvent was evaporated. The residue was hydrolyzed
by a saturated aqueous NaHCO3 solution, extracted by
CH2Cl2 and dried over MgSO4. After concentration
under reduced pressure, the residue was dissolved in CH2Cl2 and
1 equiv of DDQ was added. The solution was stirred 18 h and hydrolyzed
by a saturated aqueous K2CO3 solution. After
extraction with CH2Cl2, the organic layers
were washed, dried over MgSO4, evaporated under reduced
pressure and purified by flash chromato-graphy (SiO2)
to furnish pyrido[2,3-c]coumarins 5. Compound 5a:
Yield: 54%; mp = 133 °C; IR (KBr): 1748 cm-1;
MS : 212 (M + 1); 1H NMR (CDCl3,
250 MHz) δ 2.95 (s, 3 H, CH3), 7.34-7.58
(m, 4 H, 4CHAr), 8.26 (d, 1 H, J = 8.2
Hz, CHAr), 8.78 (d, 1 H, J = 4.6
Hz, H-6); 13C NMR (CDCl3,
62.5 MHz) δ 24.9 (CH3, ArCH3), 116,4
(C, CAr), 118.1 (CH, CHAr), 124.5 (CH, CHAr),
127.4 (CH, CHAr), 130.6 (CH, CHAr), 132.0
(CH, CHAr), 139.1 (C, CAr), 145.1 (C, CAr),
150.1 (CH, CHAr), 150.7 (C, CAr), 159.2 (C,
C=O).; Anal. Calcd for C13H9NO2:
C, 73.92; H, 4.29; N, 6.63. Found C, 73.82; H, 4.31; N, 6.72.
10
General procedure
for the synthesis of tetrahydro-pyrido[2,3-
c
]coumarins
6. In a round bottom flask equipped with a Dean-Stark
apparatus, 3-hydroxy-coumarins 3 in toluene,
CSA (cat.) and amines 4 (1.1 equiv) were
added. The solution was refluxed 6 h. The solution was cooled to
r.t. and 1.5 eq of BF3˙Et2O was added.
The solution was refluxed 18 h and the solvent was evaporated. The residue
was hydrolyzed by a saturated aqueous NaHCO3 solution,
extracted by CH2Cl2 and dried over MgSO4.
After concentration under reduced pressure, the residue was dissolved
in AcOH and 1 equiv of NaBH3CN was added. The solution
was stirred 8 h and hydrolyzed by a saturated aqueous K2CO3 solution.
After extraction with CH2Cl2, organic layers
were washed, dried over MgSO4, evaporated under reduce
pressure and purified by flash chromatography (SiO2,
CH2Cl2/MeOH, 98:2) to furnish tetrahydro-pyrido[2,3-c]coumarins 6.
Compound 6a: Yield: 63%; mp = 108 °C;
IR (KBr): 1705 cm-1; MS : 216 (M + 1); 1H
NMR (CDCl3, 250 MHz) δ 1.31 (d, 3 H, J = 7.0 Hz, CH3),
1.79-2.02 (m, 2 H, H-5), 3.17-3.24 (m, 1 H, H-4),
3.41-3.47 (m, 2 H, H-6), 4.87 (brs, 1 H, NH), 7.19-7.51
(m, 4 H, 4CHAr); 13C NMR
(CDCl3, 62.5 MHz) δ 21.2 (CH3, CH3),
25.3 (CH, C-4), 26.8 (CH2, C-5), 36.1 (CH2,
C-6), 116.7 (CH, CHAr), 120.3 (C, CAr), 121.1
(CH, CHAr), 121.1 (C, CAr), 124.5 (CH, CHAr),
125.6 (CH, CHAr), 127.8 (C, CAr), 148.1 (C,
CAr), 159.0 (C, C=O).; Anal. Calcd for C13H13NO2:
C, 72.54; H, 6.09; N, 6.51. Found C, 72.61; H, 6.23; N, 6.72.
11
General procedure
for the synthesis of pyrido[3,2-
c
]coumarins 10. Following the same
protocol described for the synthesis of pyrido[2,3-c]coumarins 5,
pyrido[3,2-c]coumarins 10 were obtained starting from 4-hydroxy-coumarin.
Compound 10a: Yield: 61%; mp = 160 °C;
IR (KBr): 1731 cm-1; MS: 212 (M + 1); 1H
NMR (CDCl3, 250 MHz) δ 2.85 (s, 3 H, CH3),
7.26-7.37 (m, 3 H, 3 CHAr), 7.53 (td, 1 H, J = 7.6 Hz, 1.7 Hz, CHAr),
8.53 (dd, 1 H, J = 7.6 Hz, 1.7,
CHAr), 8.75 (d, 1 H, J = 4.9
Hz, CHAr); 13C NMR (CDCl3,
62.5 MHz) δ 23.0 (CH3, ArCH3), 116.5
(CH, CHAr), 116.7 (C, CAr), 119.5 (C, CAr),
124.6 (CH, CHAr), 125.3 (CH, CHAr), 126.7
(CH, CHAr), 132.1 (CH, CHAr), 152.4 (C, CAr), 153.0
(C, CAr), 153.5 (C, CAr), 154.2 (CH, CHAr),
160.5 (C, C=O); Anal. Calcd for C13H9NO2:
C, 73.92; H, 4.29; N, 6.63. Found C, 73.78; H, 4.32; N, 6.68.